tirzepatide-weight management 2.5 mg/0.5ml solution auto-injector Mounjaro Injection Mounjaro Weight Loss Injection

Continuing Titration: For individuals who, in consultation with their provider, require continued titration and are tolerating the medication well, proceeding to a higher dose is a standard clinical approach

Were open five days a week and accepting new patientsno referral needed

Please call us on (571) 341-8787 or Email at [email protected]

Potential side effects include: Water retention (especially early in the protocol) Mild joint discomfort or stiffness Temporary fatigue or lethargy Flushing or warmth at the injection site Headaches (typically mild and transient) Most side effects are dose-dependent and resolve with dosage adjustment

FDAs Concerns with Unapproved GLP-1 Drugs Used for Weight Loss

Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus